Get a Quote

Home » Billing & Coding Guides » CPT Code 80053: Comprehensive Metabolic Panel Billing Guide (2026)

CPT Code 80053: Comprehensive Metabolic Panel Billing Guide (2026)

• 11 mins read
CPT Code 80053: Comprehensive Metabolic Panel Billing (2026)

Table of Contents

  • CPT code 80053 reports the comprehensive metabolic panel, a single code for 14 blood tests covering kidney and liver function, electrolytes, glucose, calcium, and protein. 
  • 80053 and 80048 (the basic metabolic panel) cannot be billed together; NCCI treats the BMP as a subset of the CMP, and no modifier overrides the edit. 
  • Under CMS NCCI rules, the 14 components cannot be billed separately when a CMP is performed; only a test outside the panel is billed on its own. 
  • A CMP needs a documented ICD-10 diagnosis supporting medical necessity, such as diabetes or chronic kidney disease; a routine panel without a covered reason denies. 
  • 80053 is priced under the Clinical Laboratory Fee Schedule, not the Physician Fee Schedule, at a low flat national rate with no patient deductible or coinsurance. 
     

80053 is one of the most frequently ordered lab tests in American medicine, and one of the easiest to overbill without meaning to. It is a panel: a single code that stands in for 14 individual blood tests. That bundling is the whole point, and it is also where the denials come from. Bill the comprehensive metabolic panel alongside a basic metabolic panel, or alongside its own component tests, and you hit a hard National Correct Coding Initiative edit that no modifier can fix. This guide covers what 80053 is, how it differs from the BMP, the panel math that decides what you can and cannot bill with it, and the medical-necessity and reimbursement rules that get it paid. 

Current as of 2026. Always verify code status and payment with your specific payer, since policies change.

What 80053 covers

80053 reports a comprehensive metabolic panel (CMP): a group of 14 blood tests that together give a broad picture of kidney function, liver function, electrolytes, blood sugar, and protein. It is ordered broadly, in primary care, endocrinology, rheumatology, nephrology, and hospital settings, for screening at a physical, monitoring a chronic condition like diabetes or hypertension, and checking organ function during drug therapy. The test runs on a serum or plasma sample, and fasting is preferred when an accurate glucose is needed. 

One rule underlies all the billing: to report 80053, the lab has to perform and result all 14 components. Billing the panel when fewer were run is an audit risk, and partial panels are billed with the individual component codes instead. 

Components of the comprehensive metabolic panel (80053)

The CMP includes 14 tests, grouped by what they assess: 

  • Kidney function (2): blood urea nitrogen (BUN) and creatinine 
  • Electrolytes and fluid balance (4): sodium, potassium, chloride, and carbon dioxide (bicarbonate) 
  • Blood sugar (1): glucose 
  • Calcium (1): total calcium 
  • Protein (2): albumin and total protein 
  • Liver function (4): ALT, AST, alkaline phosphatase, and total bilirubin 

The liver group is what separates the CMP from the basic metabolic panel. All 14 must be performed and resulted to bill 80053; if fewer are run, report the individual component codes instead.

Medical Billing

Neolytix manages the full billing lifecycle across specialties, from clean claim submission to denial resolution, with reporting that gives you full visibility into performance.

80053 vs 80048: CMP or BMP

The most common 80053 question is how it relates to the basic metabolic panel, 80048. The difference is the liver. 

Feature 

80048 (BMP) 

80053 (CMP) 

Number of tests 

8 

14 

Covers 

Glucose, calcium, electrolytes, kidney markers 

The BMP tests plus 6 liver and protein tests 

Added tests 

None 

Albumin, total protein, ALT, AST, alkaline phosphatase, total bilirubin 

Use 

Electrolyte and kidney monitoring 

Broad screening and organ-function monitoring 

Billed together? 

No; the BMP is part of the CMP 

 N/A

Every test in the BMP is already inside the CMP, so when a CMP is performed, you bill 80053 only. Two errors follow from getting this wrong: billing both panels together (which denies, below), and billing a CMP when only a BMP was actually performed, which is upcoding to the higher-value panel. 

The panel math: what you can and cannot bill with 80053

This is the core of 80053 billing, and it comes down to the NCCI rule that a panel code is a column-one code against every test it contains. CMS pricing (Claims Processing Manual, Chapter 16) reinforces it: a panel pays the lower of the billed charges, the panel fee, or the sum of the components, so there is no advantage to splitting it apart. 

What cannot be billed with 80053: 

  • The 14 component tests, billed individually. Reporting glucose, potassium, or ALT on a separate line alongside the CMP is unbundling and denies. 
  • 80048 (BMP). A hard edit; no modifier overrides it. 
  • 80076 (hepatic function panel). Its liver tests overlap the CMP’s, so it is bundled. 

What can be billed with 80053, when ordered and medically necessary: 

  • A test that is not part of the CMP, reported on its own code. For example, direct bilirubin (82248) is not in the panel, so a CMP plus a separate direct bilirubin is billed as 80053 plus 82248, not as the hepatic panel. Phosphorus (84100) is another test outside the CMP that can be added. 

The principle: bill the panel, then add only tests that fall outside it.

Medical necessity and ICD-10

A CMP must be tied to a documented diagnosis that supports it. There is no national coverage determination or code-specific policy for 80053, so coverage rests entirely on medical necessity, and a mismatched or missing diagnosis is a leading denial. Link an ICD-10 code that justifies the panel: a chronic condition being monitored, a symptom being worked up, or drug-therapy monitoring. Common supporting examples include type 2 diabetes (E11.9), chronic kidney disease (N18.x), essential hypertension (I10), and long-term drug therapy monitoring (Z79.x). A panel ordered out of habit, with no supporting indication, is exposed. 

Frequency is the related issue. Payers limit how often a CMP is covered for routine monitoring, and billing it more often than the interval allows, without a documented reason, denies. For stable patients, guidelines also discourage reflexive repeat chemistry testing, so the record should show why each panel was needed. 

Modifiers for 80053

A standard CMP is billed as 80053 with no modifier. The ones that apply in specific situations: 

  • Modifier 91: a medically necessary repeat of a test on the same day to obtain a new clinical result, such as a potassium recheck after treatment. It is the most misapplied lab modifier. It does not apply to re-running a test because of a specimen or equipment problem, and it does not override the 80048 edit. 
  • Modifier 90: identifies a reference (outside) laboratory when the billing entity did not perform the test. 
  • Modifier QW: used when the panel is run on an FDA-cleared CLIA-waived system. 

Two technical notes: there is no professional or technical split on a lab panel, so modifiers 26 and TC do not apply, and a Medically Unlikely Edit caps 80053 at one unit per patient per day, so a legitimate second panel requires modifier 91 and documentation.

Reimbursement: the Clinical Laboratory Fee Schedule

Here is the point most billing guides miss or get wrong. 80053 is not paid under the Medicare Physician Fee Schedule. It is priced under the Clinical Laboratory Fee Schedule (CLFS), at a low flat national rate in the range of around ten dollars, with payment set as the lower of the billed amount or the fee schedule rate. Because it is a CLFS service, the Medicare deductible and coinsurance do not apply, so the patient generally owes nothing. 

The rate varies by Medicare Administrative Contractor locality and updates each January, so confirm the current amount through the CMS Clinical Laboratory Fee Schedule rather than the Physician Fee Schedule tool. The economics of 80053 are entirely about clean, necessary, correctly-bundled volume, since the per-claim amount is small and a single unbundling error both overstates the claim and invites recoupment. Our guide to CPT code 36415 covers the same CLFS logic for the blood draw itself.

The bottom line

80053 is a high-volume, low-dollar panel where the money is won or lost on the bundling rules, not the rate. Bill the panel, never its components or the BMP alongside it, add only tests that fall outside the CMP, link a diagnosis that supports necessity, use modifier 91 only for a true same-day repeat, and price it from the lab fee schedule. For practices that would rather not run the panel math and necessity checks test by test, Neolytix has supported healthcare organizations across the United States for over 14 years, with laboratory coding review built into its medical billing services so panel claims are clean before they go out.

Schedule a Consultation

Neolytix partners with healthcare organizations across revenue cycle, credentialing, and administrative operations ,14+ years of expertise and AI-enabled automation to reduce inefficiencies and drive sustainable growth.

This guide reflects Neolytix’s expertise in healthcare revenue cycle management and is intended for educational purposes only. It does not constitute legal or compliance advice. CPT codes and reimbursement rates are periodically updated by the AMA and CMS.

Sources

Frequently Asked Questions

What is CPT code 80053 used for?

80053 reports a comprehensive metabolic panel, a single code covering 14 blood tests: kidney markers, liver enzymes, electrolytes, glucose, calcium, and protein. It is used as a broad screening and monitoring panel in primary care, endocrinology, rheumatology, and hospital settings, for conditions like diabetes, kidney disease, and liver disease. All 14 components must be performed to bill it.

No. Under NCCI edits, 80048 (the basic metabolic panel) is a column-two code of 80053, because every BMP test is already part of the CMP. They cannot be billed together on the same specimen under any circumstances, and no modifier overrides the edit. When a CMP is performed, bill 80053 only.

Usually not. A standard CMP is billed as 80053 alone. Modifier 91 applies to a medically necessary repeat of a component on the same day, such as a potassium recheck after treatment, not a re-run of a failed test. Modifier 90 identifies a reference lab. There is no 26 or TC component for a lab panel.

A basic metabolic panel (80048) has 8 tests: glucose, calcium, electrolytes, and kidney markers. A comprehensive metabolic panel (80053) has those plus 6 liver and protein tests (albumin, total protein, ALT, AST, alkaline phosphatase, and bilirubin), for 14 total. The CMP is the broader panel; bill the one that was actually ordered and performed.

80053 is priced under the Clinical Laboratory Fee Schedule, not the Physician Fee Schedule, at a low flat national rate in the range of around ten dollars. The exact amount varies by Medicare Administrative Contractor locality and updates each January. Patients generally owe nothing, since the deductible and coinsurance do not apply to lab fee schedule services.

Share:

Table of Contents

Credentialing Delays Are Costing You $45K–$150K Per Provider

  • Cut Credentialing Cycle Times From 120 Days to Under 45
  • Free Downloadable Guide

Neolytix Identifies an Average of $341K in Payer Contract Revenue Opportunities — Get Your Assessment Done Today

Free live webinar

Acquiring or merging a practice? Plan for the cash gap before it occurs.

Join Ritu Bhatnagar, Neolytix’s Founder and COO, and Chris Marchese, COO of  vybe urgent care, for Enrollment 101 for Healthcare M&A : A live playbook for payer enrollment, billing and cash flow through the deal.

Keynote Speakers

Ritu Bhatnagar
Founder and Chief Operating Officer, Neolytix
Chris Marchese
Chief Operating Officer, Vybe Urgent Care

Getting GLP-1s Approved:

End-to-End Prior Authorization for Obesity Programs

A 45-minute working session with the CEO of Neolytix and CMO of PrescriberPoint on improving first-pass approvals and shortening time-to-treatment.

Keynote Speakers

Raj Bhatnagar

Chief Executive Officer, Neolytix

Dr. Steve Strongwater
Chief Medical Officer, PrescriberPoint